Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 385

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 385
---
 because the exercise price in respect of such Warrant is greater than the Cash Amount, neither the Company nor the        
 Purchaser shall be obligated to pay the holder of such Warrant the Consideration or any other amount in respect of such Warrant, and such Warrant shall be immediately cancelled and surrendered for no consideration. In addition, (i) the former        
 holder of the Warrant shall cease to be a holder of such Warrant, (ii) such holder’s name shall be removed from the register of Warrants, (iii) the Warrant agreement and any and all subscription or similar agreements relating to the                  
 Warrant shall be terminated and shall be of no further force and effect; and (iv) such holder shall cease to have any rights as a holder in respect of such Warrant;                                                                                      |

| (f) | each Common Share outstanding immediately prior to the Effective Time held by a Dissenting Shareholder shall be                                                                                                                                   
 deemed to have been transferred (free and clear of all Encumbrances), without any further act or formality by or on behalf of any Dissenting Shareholder, to the Purchaser, in consideration for a debt claim against the Purchaser for an amount 
 determined under Article 3, and:                                                                                                                                                                                                                  |

| (i) | such Dissenting Shareholder shall cease to be the registered holder of such Common Share and to have any rights                
 as a Shareholder other than the right to be paid the Fair Value by the Purchaser for such Common Share set out in Section 3.1; |

| (ii) | such Dissenting Shareholder’s name shall be removed as the registered holder of Common Shares from the 
 applicable register of Shareholders maintained by or on behalf of the Company; and                     |

| (iii) | the Purchaser shall be deemed to be the transferee of such Common Shares free and clear of all Encumbrances and 
 shall be entered in the register of the Shareholders maintained by or on behalf of the Company;                 |

| (g) | each Common Share outstanding immediately prior to the Effective Time (other than a Common Share held by a                                                                                                                                         
 Dissenting Shareholder in respect of which Dissent Rights have been validly exercised under Section 2.3(f), the Purchaser or any affiliate of the Purchaser) shall be deemed to be assigned and transferred by the holder thereof to the Purchaser 
 in exchange for the issuance by the Purchaser of one CVR per Common Share, and:                                                                                                                                                                    |

| (i